
Results
2
2 companies
Hyloris Pharmaceuticals
Market Cap: €211.1m
Engages in the research, development, and manufacture of pharmaceutical products to address medical needs.
HYL
€7.54
7D
0.8%
1Y
45.0%
argenx
Market Cap: €42.9b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€700.80
7D
-2.3%
1Y
12.4%